홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
FULC
#2892
Fulcrum Therapeutics, Inc. Common Stock
7.9
1
USD
+2.33%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+2.33%
월간 변동
+1.80%
6달 변화
-9.60%
년간 변동율
+171.82%
이전 종가
7.7
3
Open
7.9
0
Bid
Ask
Low
7.9
0
High
7.9
1
양
243
마켓
주식
헬스케어
FULC
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
32.67 M
40.64 M
61.76 M
61.94 M
53.98 M
66.6 M
—
Valuation ratios
Enterprise value
325.54 M
683.46 M
452.8 M
420.99 M
195.49 M
555.72 M
1.45 B
Price to earnings ratio
—
—
-3.24
-4.53
-29.38
-9.58
-14.02
Price to sales ratio
—
—
0.06
0.16
0
—
—
Price to cash flow ratio
—
—
-0
-0
-0.13
-0.01
-0.08
Price to book ratio
—
—
0
0
0
0
0.01
EBITDA 비율에 대한 기업 가치
-4.7
-8.78
-4.12
-3.68
-7.92
-6.44
-23.07
Profitability ratios
Return on assets %
-0.55
-0.34
-0.48
-0.38
-0.04
-0.2
-0.3
Return on equity %
-0.74
-0.38
-0.55
-0.41
-0.04
-0.21
-0.31
Return on invested capital %
-694.39
-255.15
-242.06
-217.3
-41.52
-188.47
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
-811.64
-422.97
-1 774.85
-3 945.24
-27.37
—
—
EBITDA margin %
-785.45
-406.34
-1 734.39
-4 081.39
-30.87
—
—
Net margin %
-802.66
-421.89
-1 732.43
-3 470.05
-12.16
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.47
11.77
12.41
17.71
22.63
27.4
98.22
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.03
0.01
0.31
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2 157.1
-1 483.69
-35.78
-948.07
-270.23
EBIT per share
—
—
-2 501.86
-1 804.99
-353.27
-1 338
-365.49
EBITDA per share
—
—
-2 444.82
-1 867.28
-398.43
-1 362.67
-364.83
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
780.11
416.95
939.15
3 117.88
3 133.39
Net current asset value per share
—
—
4 612.46
3 950.4
4 032.06
5 642.49
5 719.88
Tangible book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
5 518.9
Working capital per share
—
—
4 240.71
3 727.35
3 853.88
5 436.54
5 510.55
Book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
5 584.08
뉴스
Agios Rallies On A Surprise FDA Move In Sickle Cell, Pulling Rival Fulcrum Higher
Fulcrum, 낫적혈구병 전략 집중: Leerink 컨퍼런스
Fulcrum Therapeutics at Leerink Conference: Strategic Focus on Sickle Cell
풀크럼 테라퓨틱스, 입센 철수로 압박받을 수도: 스티펠
Fulcrum Therapeutics stock may face pressure on Ipsen withdrawal, Stifel says
Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)
풀크럼 테라퓨틱스, 겸상 적혈구 임상 시험 목표 미달로 주가 하락
Fulcrum Therapeutics stock falls as sickle cell trial misses target
리어링크, 겸상 적혈구병 데이터에 풀크럼 테라퓨틱스 투자의견 재확인
Leerink reiterates Fulcrum Therapeutics stock rating on SCD data
BofA, 풀크럼 테라퓨틱스에 ’저조한 실적’ 투자의견 유지, 목표가 7달러
BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7